| ASSET | YEAR | % RETURN |
|---|---|---|
Corcept Therapeutics (CORT) | 2009 | 157.41% |
Corcept Therapeutics (CORT) | 2010 | 35.44% |
Corcept Therapeutics (CORT) | 2011 | -11.86% |
Corcept Therapeutics (CORT) | 2012 | -59.26% |
Corcept Therapeutics (CORT) | 2013 | 111.18% |
Corcept Therapeutics (CORT) | 2014 | -6.83% |
Corcept Therapeutics (CORT) | 2015 | 65.45% |
Corcept Therapeutics (CORT) | 2016 | 49.69% |
Corcept Therapeutics (CORT) | 2017 | 147.74% |
Corcept Therapeutics (CORT) | 2018 | -26.07% |
Corcept Therapeutics (CORT) | 2019 | -7.84% |
Corcept Therapeutics (CORT) | 2020 | 115.66% |
Corcept Therapeutics (CORT) | 2021 | -24.02% |
Corcept Therapeutics (CORT) | 2022 | 2.52% |
Corcept Therapeutics (CORT) | 2023 | 59.22% |
Corcept Therapeutics (CORT) | 2024 | 127.91% |
Corcept Therapeutics (CORT) | 2025 | -31.25% |
Corcept Therapeutics (CORT) | 2026 | 225.03% |